Skip to content
TrialScanner

NCT03424603

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Phase 1CompletedSTROLead

Registry record

Lead sponsor
Sutro Biopharma, Inc.
Conditions
B-cell Lymphoma; Non Hodgkin Lymphoma; Multiple Myeloma; Follicular Lymphoma; Mantle Cell Lymphoma
Primary completion
Feb 15, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03424603 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03424603: Study of STRO-001, an... | TrialScanner